GABAB receptor complex as a potential target for tumor therapy

Area of Science:

• Neuroscience
• Molecular Biology
• Oncology

Background:

• γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the vertebrate central nervous system.
• Metabotropic GABA(B) receptors are G-protein-coupled receptors (GPCRs) composed of GABA(B1) and GABA(B2) subunits.
• The C-terminal domains of GABA(B) receptors are crucial for receptor complex formation and interactions with other proteins.

Purpose of the Study:

• To explore the role and therapeutic potential of GABA(B) receptors in human cancers.
• To investigate the structural diversity and functional implications of GABA(B) receptor isoforms.
• To understand the mechanisms by which GABA(B) receptor activation affects tumor cell behavior.

Main Methods:

• Analysis of GABA(B) receptor subunit expression, including splice variants (GABA(B1a), GABA(B1b), and minor isoforms).
• Investigation of GABA(B) receptor agonist (baclofen) effects on tumor growth in preclinical models.
• Examination of cellular signaling pathways (CREB, ERK) affected by GABA(B) receptor activation in tumor cells.

Main Results:

• Increased expression of GABA(B) receptors is observed in human cancer cells and tissues.
• GABA(B) receptor agonist baclofen demonstrated tumor growth inhibition in rat models.
• Activation of GABA(B) receptors suppressed proliferation and migration of human tumor cells, alongside inactivation of CREB and ERK signaling.

Conclusions:

• GABA(B) receptors exhibit significant structural diversity, with various isoforms potentially playing roles in cancer.
• GABA(B) receptor signaling pathways are implicated in the regulation of tumor cell proliferation, migration, and survival.
• The diverse nature of GABA(B) receptors presents them as promising therapeutic targets for specific human cancers.